Share
Market Research Report

CARDIOVASCULAR AND SOFT TISSUE REPAIR PATCHES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Material TypeSynthetic Patches (Expanded Polytetrafluoroethylene (ePTFE), Polyester, and Polypropylene and Other Synthetic Materials) · Biologic Patches (Bovine Pericardium, Porcine-Derived Tissue Matrices, and Human-Derived Tissue Matrices) · and Tissue-Engineered and Composite Patches
  • By ApplicationCardiac Repair (Atrial and Ventricular Septal Defect Repair and Valve Reconstruction and Other Cardiac Repair) · Vascular Repair and Reconstruction (Carotid and Peripheral Vascular Repair and Other Vascular Reconstruction Procedures) · Soft Tissue Repair (Hernia Repair, Abdominal Wall Reconstruction, and Other Soft Tissue Reinforcement) · and Others
  • By End UseHospitals · Ambulatory Surgical Centers · and Specialty Cardiovascular Clinics and Surgical Centers
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In19 Nov 2026
  • Report CodeCMI10456
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • By Material Type (Revenue, USD Bn, 2021-2033)

    • Synthetic Patches
      • Expanded Polytetrafluoroethylene (ePTFE)
      • Polyester
      • Polypropylene and Other Synthetic Materials
    • Biologic Patches
      • Bovine Pericardium
      • Porcine-Derived Tissue Matrices
      • Human-Derived Tissue Matrices
    • Tissue-Engineered and Composite Patches
  • By Application (Revenue, USD Mn, 2021-2033)

    • Cardiac Repair
      • Atrial and Ventricular Septal Defect Repair
      • Valve Reconstruction and Other Cardiac Repair
    • Vascular Repair and Reconstruction
      • Carotid and Peripheral Vascular Repair
      • Other Vascular Reconstruction Procedures
    • Soft Tissue Repair
      • Hernia Repair
      • Abdominal Wall Reconstruction
      • Other Soft Tissue Reinforcement
    • Others
  • By End Use (Revenue, USD Mn, 2021-2033)

    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Cardiovascular Clinics and Surgical Centers
  • By Region (Revenue, USD Mn, 2021-2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
  • Key Players

    • LeMaitre Vascular
    • W. L. Gore & Associates
    • Baxter International
    • Artivion
    • B. Braun
    • BD
    • TELA Bio
    • Integra LifeSciences
    • CorMatrix Cardiovascular
    • Edwards Lifesciences
    • Abbott Laboratories
    • Terumo Corporation
    • Getinge
    • Healthium Medtech
    • GUNZE